References
- Brauer R. E., Baldwin WM, III, Daha M. R., Pruitt S. K., Sanfilippo F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol. 1993; 151: 7240–7248
- Ono K., Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 1969; 57: 225–229
- Jamieson S. W. Xenograft hyperacute rejection: a new model. Transplantation. 1974; 17: 533–534
- Platt J. L., Each FH. The barrier to xenotransplantation. Transplantation. 1991; 52: 937–947
- Leventhal J. R., Dalmasso A. P., Crornwell J. W., et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation. 1993; 52: 937–866
- Leventhal J. R., Matas A. J., Sun L. H., et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation. 1993; 56: 1–8
- Leenaerts P. L., Stad R. K., Hall E. M., Van EJ Damme, Vanrenterghem Y., Daha MR. Hereditary C6 deficiency in a strain of PVGIc rats. Clin Exp Immunol. 1994; 97: 478–482
- Lindsay T. F., Hill J., Ortiz F., et al. Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemia-reperfusion. Am Surg. 1992; 216: 677–683
- Rubin B. E., Smith A., Liauw S., et al. Complement activation and white cell sequestration in postischemia skeletal muscle. Am I Physiol. 1990; 259: H525–H531
- Weisman H. F., Bartow T., Leppo M. K., et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing postischemic myocardial inflammation and necrosis. Science 1990; 249: 146–151
- Moore F. D., Warner K. U., Assousa S., et al. The effects of complement activation during cardiopulmonary bypass: attenuation by hypothermia, heparin, and hemodilution. Ann Surg. 1988; 208: 95–103